Drug Trial Radar · NCT03960385
Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - Brazil
Last checked: Nov 19, 2026Latest source record: Sep 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,854
Actual
Start
Aug 1, 2017
Primary completion
Mar 1, 2020
Study completion Mar 1, 2020
Sponsor
- Lead sponsor
- Albert B. Sabin Vaccine InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pan American Health Organization; State of Parana/Health Department of Parana; Ministry of Health, Brazil; Centro de Estudos Augusto Leopoldo Ayrosa Galvão
- First posted
- May 23, 2019
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years, up to 44 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The study seeks to assess the effectiveness of Sanofi Pasteur´s dengue vaccine (Dengvaxia®) according to the age, dose and municipality of residence in five municipalities of Paraná State. Specific objectives include: * To assess the effectiveness of Dengvaxia® in preventing dengue hospitalization and dengue symptomatic cases. * To assess the effectiveness of Dengvaxia® in preventing dengue hospitalization and dengue symptomatic cases according in the following age groups 15 to 18 and 19 to 27 years of age in the municipalities of Maringá, Foz de Iguaçu, Londrina, Sarandi and Paranaguá. * To assess the effectiveness of Dengvaxia® in preventing dengue hospitalization and dengue symptomatic cases in the following age groups 9 to 14 and 28 to 45 years of age in the municipality of Paranaguá.
Conditions
- Dengue
Interventions
CYD-TDVBiological
Dengue vaccine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dengue symptomatic caseTime frame: Aug 2017 - March 2020
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Augusto Leopoldo Ayrosa Galvão Study Center
São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.